Login / Signup

Evaluation of the plasma concentration of ponatinib in a chronic myeloid leukaemia patient with ponatinib intolerance.

Maiko AbumiyaNaoto TakahashiTomoko YoshiokaYoshihiro KameokaMasatomo Miura
Published in: Journal of clinical pharmacy and therapeutics (2020)
Monitoring of the ponatinib plasma concentration led to safe and effective CML management in a patient with higher drug bioavailability.
Keyphrases
  • chronic myeloid leukemia
  • case report
  • bone marrow
  • acute myeloid leukemia
  • dendritic cells
  • emergency department
  • drug induced
  • electronic health record